Pierre Fabre S.A.

https://www.pierre-fabre.com

Pierre Fabre is a private pharmaceuticals and dermo-cosmetics company founded in 1961 by Mr. Pierre Fabre. Its turnover reached over 2.2 billion Euros* in 2015, spread over 130 countries. The company is structured around two divisions: Pharmaceuticals (prescription drugs, consumer health care) and Dermo-cosmetics (including the Europe and Asia market-leader brand Eau Thermale Avène). Pierre Fabre employs some 11,000 people worldwide and owns subsidiaries in 43 countries. In 2015, the company allocated 16 percent of its pharmaceuticals sales to R&D with a focus on 4 therapeutic areas: oncology, dermatology, CNS and consumer health care. Pierre Fabre’s oncology expertise is based on 3 decades of experience in the discovery, development and global commercialization of innovative cancer drugs including monoclonal antibodies and natural cytotoxic agents. The company performs its oncology, onco-dermatology and dermatology R&D in two major research centres: the Pierre Fabre Immunology Centre (CIPF) based in Saint-Julien-en-Genevois (France) and the Pierre Fabre Research Institute (IRPF) located on the Toulouse-based Oncopole campus. The latter is officially recognized by the French government as a National Center of Excellence for cancer research. Pierre Fabre laboratories have always developed durable and valuable scientific partnerships with innovators from public research institutions (CRNS, Inserm, …), faculties and universities (Ecole Polytechnique de Lausanne, Université de Saclay,…), biotech companies (Array, BioPharma, AbCheck, Cellectar, …) and international pharmaceutical laboratories (Allergan, Merck & Co., Abbvie, Maruho, …). Through the Group’s controlling company Pierre Fabre Participations, Pierre Fabre is 86% owned by the Pierre Fabre Foundation, a recognized public-interest organization since 1999. Up to 7.8% of the remaining shares are held by the company’s employees and balance is held as treasury stock. AFNOR Certification has assessed the Corporate Social Responsibility policy of Pierre Fabre as “confirmed” (AFAQ 26000). *

	Start	1961-01-01 established
	Group	Pierre Fabre (Group)
	Industry	pharmaceutical
	Industry 2	cosmetics

	Region	Paris
	Country	France
	Street	Avenue Hoche
	City	75008 Paris
	Tel	+33-5-6362-3850
		Address record changed: 2020-12-02

Basic data	Employees	H: 10,001 to 50,00 (2016-02-03)
	Currency	EUR
	Annual sales	2,200,000,000 (turnover (2015) 2015-12-31)

		* Document for »About Section«:

		Record changed: 2024-03-11